434 articles – 313 Notices  [english version]
Fiche concise
PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.
Alarcon F., Bourgain C., Gauthier-Villars M., Planté-Bordeneuve V., Stoppa-Lyonnet D., Bonaïti-Pellié C.
Genetic Epidemiology 33, 5 (2009) 379-85 - http://www.hal.inserm.fr/inserm-00358140
 (19089844) 
PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.
Flora Alarcon () 1, Catherine Bourgain1, Marion Gauthier-Villars2, Violaine Planté-Bordeneuve3, Dominique Stoppa-Lyonnet2, 4, Catherine Bonaïti-Pellié1
1 :  Génétique épidémiologique et structures des populations humaines
INSERM : U535 – IFR69 – Université Paris XI - Paris Sud
Hopital Paul Brousse 94817 VILLEJUIF CEDEX
France
2 :  Service d'oncogénétique
Institut Curie
Paris
France
3 :  Service de neurologie
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôpital Bicêtre – Université Paris XI - Paris Sud
Le Kremlin Bicêtre
France
4 :  UP5 - Université Paris 5, Paris Descartes
http://www.univ-paris5.fr/
Université Paris V - Paris Descartes – Ministère de l'Enseignement Supérieur et de la Recherche Scientifique
12, rue de l'École de Médecine - 75270 Paris cedex 06
France
Providing valid risk estimates of a genetic disease with variable age of onset is a major challenge for prevention strategies. When data are obtained from pedigrees ascertained through affected individuals, an adjustment for ascertainment bias is necessary. This article focuses on ascertainment through at least one affected and presents an estimation method based on maximum likelihood, called the Proband's phenotype exclusion likelihood or PEL for estimating age-dependent penetrance using disease status and genotypic information of family members in pedigrees unselected for family history. We studied the properties of the PEL and compared with another method, the prospective likelihood, in terms of bias and efficiency in risk estimate. For that purpose, family samples were simulated under various disease risk models and under various ascertainment patterns. We showed that, whatever the genetic model and the ascertainment scheme, the PEL provided unbiased estimates, whereas the prospective likelihood exhibited some bias in a number of situations. As an illustration, we estimated the disease risk for transthyretin amyloid neuropathy from a French sample and a Portuguese sample and for BRCA1/2 associated breast cancer from a sample ascertained on early-onset breast cancer cases.
Sciences du Vivant/Génétique
Anglais
0741-0395

Articles dans des revues avec comité de lecture
10.1002/gepi.20390
Genetic Epidemiology (Genet Epidemiol)
Publisher Wiley-Blackwell
ISSN 0741-0395 (eISSN : 1098-2272)
internationale
07/2009
16/12/2008
33
5
379-85

Ascertainment bias – risk estimation – penetrance function – maximum likelihood method
Age Factors – Amyloid Neuropathies – Bias (Epidemiology) – Breast Neoplasms – France – Genes – BRCA1 – BRCA2 – Genetic Diseases – Inborn – Humans – Likelihood Functions – Models – Genetic – Statistical – Pedigree – Phenotype – Portugal – Prealbumin – Risk
Liste des fichiers attachés à ce document : 
DOC
PEL_version_def.doc(442.5 KB)
PDF
PEL_version_def.pdf(349.3 KB)
inserm-00358140_edited.pdf(266.7 KB)
XHTML
index.xhtml(66.2 KB)